Clinical Pharmacokinetics of Contraceptive Steroids An Update

Clinical Pharmacokinetics

Volumn 20, Issue 1, 1991, Pages 15-37

  Shenfield, Gillian M ^a   Griffin, Judith M ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN; DESOGESTREL; ETHINYLESTRADIOL; GESTODENE; LEVONORGESTREL; NORETHISTERONE; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; PREDNISOLONE; TRICYCLIC ANTIDEPRESSANT AGENT;

BREAST MILK; DRUG INTERACTION; DRUG METABOLISM; HUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW;

CONTRACEPTIVES, ORAL, HORMONAL; DRUG INTERACTIONS; FEMALE; HUMAN; PREGNANCY; STEROIDS;

EID: 0026061544     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-199120010-00002     Document Type: Article

References (106)

1. Impairmcnl of diazepam clearance with low-dose oral contraceptive steroid therapy
2. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives
3. Imipramine disposition in users of oral contraceptive steroids
4. Impairment of cafeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives
5. Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills
6. Vitamin metabolism and the effects of multivitamin supple-mentation in oral contraceptive users
7. Sex hormone binding globulin
8. Sex hormone binding globulin: its relevance to oral contraception
9. The pharmacokinetics of norcthindrone in women (1): radioimmunoassay and concentrations during multiple dosing
10. An investigation of the pharmacokinetics of ethinylestradiol in women using radioimmunoassay
11. Pharmacokinetics of oral contraceptive steroids following the administration of the antimalarial drugs primaquine and chloroquine
12. Drug interactions involving oral contraceptive steroid therapy
13. Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics
14. Comparative pharmacokinetics of levonorgestrel and ethinyl-oestradiol following intravenous, oral and vaginal administration
15. Plasma concentrations of 3-keto-desogestrel after oral administration of desogestrel and intravenous administration of 3-keto-desogestrel
16. The relative bioavailability of levonorgestrel and ethinyloes-tradiol when administered in tablet and capsule form
17. 2-Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and anlipvrine
18. Binding of a contraceptive progestogen ORG 2969 and its metabolite to receptor proteins and human sex hormone binding globulin
19. ICMR Task Force study on hormonal contraception. Transfer of norethisterone (NET) and levonorgestrel (LNG) from a single tablet into the infant’s circulation through the mother’s milk
20. Prednisolone disposition and protein binding in oral contraceptive users
21. Reversed-phase high performance liquid chromatography for the determination of steroid hormones in oral contraceptives
22. General reversed-phase high-perfomance liquid chromatography procedure for the analysis of oral contraceptive formulations
23. Effects of the contraceptive pill on sedative responses to Clonidine and apomorphine in normal women
24. Norethisterone concentration in breast milk and infant and maternal plasma during cthynodiol diacetate administration
25. Oral contraceptive steroid plasma concentrations in smokers and nons-mokers
26. The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids
27. Drug interactions with oral contraceptives
28. Oral contraceptive interaction ith cvclosporin
29. Interaction of anticonvulsants and oral contraceptives in epileptic adolescents
30. Therapeutic drug monitoring of amitryptiline: impact of age, smoking and contraceptives on drug and metabolite levels in bulimic women
31. Effects of oral contraceptives on diazepam-induced psychomotor impairment
32. Why do inadvertent pregnancies occur in oral contraceptive users? Effectiveness of oral contraceptive regimens and interfering factors
33. Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone
34. The relative bioavailability of levonorgestrel and ethinyl estradiol administered as a low-dose combination oral contraceptive
35. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol
36. The relative impact of smoking and oral contraceptive use on women in the United States
37. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women
38. Pharmacology of contraceptive steroids: a brief review
39. The effect of cotrimoxazole on oral contraceptive steroids in women
40. The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomy
41. Clinical pharmacokinetics of valproic acid
42. Scrum steroid binding protein concentrations, distribution of progestogens and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel
43. Serum levels of 3-keto-desogestrel after administration of desogestrel and 3-keto-deso-grestrel
44. Interactions between ethanol and oral contraceptive steroids
45. Alterations in the kinetics of prednisolone in women receiving oral contraceptives
46. Influence of sex, menstrual cycle and oral contraception on the disposition of nitrazepam
47. Ethanol metabolism in women taking oral contraceptives
48. Antacid does not reduce the bioavailability of oral contraceptive steroids in women. International Journal of Clinical Pharmacology
49. Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone
50. Influence of cigarette smoking on drug metabolism in man
51. Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking
52. β Adrenoceptor blocker pharmacokinetics and the oral contraceptive pill
53. Contraceptive efficacy of the pill
54. Inadvertent pregnancies in oral contraceptive users
55. Pharmacodynamic evaluation of the benzodiazepine-oral contraceptive interaction
56. Pharmacokinetics of progestogens
57. Serum levels of 3-keto-de-sogestrcl and SHBG during 12 cycles of treatment with 30μg ethinyleslradiol and 150μg desogcstrel
58. Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30μg ethinyleslradiol and 75μg gestodene
59. A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel
60. Lack of impairment of fluocortolone disposition in oral contraceptive users
61. Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives
62. Drug-induced liver damage related to the combined use of cyclosporin A and a contraceptive
63. The use of polyethyleneglycol in radioimmunoassays using tritium labels
64. Metabolism of the contraceptive steroid norgestimate by the human gut and liver in vitro
65. Oral contraceptives and griseoful-vin interaction
66. Brooks PM
67. Influence of sex and oral contraceptive steroids on paracetamol metabolism
68. Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acctylsalicylic acid
69. Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination
70. Effects of oral contraceptive steroids on acetaminophen metabolism and elimination
71. Pharmacokinetics of ethynyl estradiol: a current view
72. Absorption of an oral contraceptive gestogen in ulcerative colitis before and after proctocolectomy and construction of a continent ileostomy
73. Bromazepam pharmacokinetics: influence of age, gender, oral contraceptives. Cimetidine and propranolol
74. Disposition of clotiazepam: influence of age, sex, oral contraceptives. Cimetidine, isoniazid and elhanol
75. Enhanced metabolism of levonorgestrel during Phenytoin treatment in a woman with Norplant® implants
76. Interactions between oral contraceptive steroids and broad-spectrum antibiotics
77. Clinical pharmacokinetics of oral contraceptive steroids
78. Use of oral contraceptives by women with epilepsy
79. Lack of hepatic enzyme inducing effect of sodium valproate
80. Effects of varying amounts of ethinyloestradiol in the combined oral contraceptive on plasma sex hormone binding globulin capacity in normal women
81. The new generation of monophasic oral conraceptives
82. Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives
83. Oral contraceptive steroids impair the elimination of theophylline
84. Intestinal metabolism of ethinyloestradiol and paracetamol in vitro: studies using Ussing chambers
85. Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol
86. Cyclosporin interaction with danazol and norethisterone
87. New progestogens in oral contraceptives
88. Vaginal administration of ethinyleslradiol: effects on ovulation and hepatic transcorlin synthesis
89. A non-chroma-tographic radioimmunoassay for 3-oxo desogcstrel
90. Drug interactions with oral contraceptive preparations
91. Plasma hormone concentrations in women on the oral contraceptive pill
92. Pharmacokinetics of norelhisterone in humans
93. Pharmacokinetic studv of Icvonorgcsirel used as a postcoital agent
94. Pill method failures
95. Pregnancies in reliable pill takers
96. Variation of ethmyloestradiol blood levels among healthy women using oral contraceptives
97. Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis
98. Effects of oral contraceptives on triazolam, lemazepam, alprazolam and lorazepam kinetics
99. Interaction between oral contraceptives and griseofulvin
100. Radioimmunoassay of plasma norethisterone after ethynodiol diacelate administration
101. Radioimmunoassay of synthetic progestogens, norethisterone and norgestrel
102. Effects of sex and the oral contraceptive pill on morphine disposition
103. Suppression of ovulation by transdermal oestradiol patches
104. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone
105. Sex-related differences in drug disposition in man
106. Pharmacokinetic and pharmacodynamic studies of vaginal rings releasing low-dose levonorgestrel